Brainstorm Cell Therapeutics Inc. (BCLI)

Deferred Revenue

$0.00

Quarterly · Period ending: · USD

BCLI logo

BCLI Deferred Revenue

Latest reported$0.00
BCLI Quarterly Deferred Revenue ($0.00 → $0.00)
High-resolution chart · PNG

BCLI deferred revenue history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Brainstorm Cell Therapeutics Inc. Deferred Revenue — Quarterly (USD)
Period endingDeferred Revenue (USD)
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
511,000
0
130,000
1,885,000
1,202,000
2,625,000
5,250,000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
6,509
0
0
0
0
0
0
0
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.